Literature DB >> 26603829

The importance of surgical margins in pancreatic cancer.

Cecilia G Ethun1, David A Kooby1.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with a grim prognosis. Surgical resection offers the best chance for long-term survival, yet recurrence rates are high and outcomes are poor. The influence of margin status in PDAC is controversial, as conflicting data have been plagued by a lack of standardization in margin definitions, pathologic analysis, and reporting. Despite recent efforts, international consensus is still needed for this disease.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  R1 resection; intraoperative frozen section; margin status; pancreaticoduodenectomy; survival

Mesh:

Year:  2015        PMID: 26603829     DOI: 10.1002/jso.24092

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  25 in total

Review 1.  Tumor Biological Aspects of Epithelial versus Mesenchymal Tumors of the Gastrointestinal Tract.

Authors:  Chandrajit P Raut
Journal:  Visc Med       Date:  2018-10-28

2.  CT texture analysis of pancreatic cancer.

Authors:  Kumar Sandrasegaran; Yuning Lin; Michael Asare-Sawiri; Tai Taiyini; Mark Tann
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

3.  Imaging of targeted lipid microbubbles to detect cancer cells using third harmonic generation microscopy.

Authors:  Kaitlin Harpel; Robert Dawson Baker; Babak Amirsolaimani; Soroush Mehravar; Josef Vagner; Terry O Matsunaga; Bhaskar Banerjee; Khanh Kieu
Journal:  Biomed Opt Express       Date:  2016-06-28       Impact factor: 3.732

4.  Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer.

Authors:  Masaru Miyazaki; Hideyuki Yoshitomi; Shigetsugu Takano; Hiroaki Shimizu; Atsushi Kato; Hiroyuki Yoshidome; Katunori Furukawa; Tsukasa Takayashiki; Satoshi Kuboki; Daisuke Suzuki; Nozomu Sakai; Masayuki Ohtuka
Journal:  Langenbecks Arch Surg       Date:  2017-03-30       Impact factor: 3.445

5.  Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.

Authors:  Laura R Prakash; Huamin Wang; Jun Zhao; Graciela M Nogueras-Gonzalez; Jordan M Cloyd; Ching-Wei D Tzeng; Michael P Kim; Jeffrey E Lee; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

Review 6.  The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  Expert Rev Anticancer Ther       Date:  2018-05-28       Impact factor: 4.512

Review 7.  Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2018-08-06       Impact factor: 3.454

8.  Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.

Authors:  Thinzar M Lwin; Sophie Hernot; Hannah Hollandsworth; Siamak Amirfakhri; Filemoni Filemoni; Pieterjan Debie; Robert M Hoffman; Michael Bouvet
Journal:  Surgery       Date:  2020-05-04       Impact factor: 3.982

9.  Towards a More Standardized Approach to Pathologic Reporting of Pancreatoduodenectomy Specimens for Pancreatic Ductal Adenocarcinoma: Cross-continental and Cross-specialty Survey From the Pancreatobiliary Pathology Society Grossing Working Group.

Authors:  Deepti Dhall; Jiaqi Shi; Daniela S Allende; Kee-Taek Jang; Olca Basturk; Volkan Adsay; Grace E Kim
Journal:  Am J Surg Pathol       Date:  2021-10-01       Impact factor: 6.298

10.  Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma.

Authors:  Eddie Zhang; Lora Wang; Talha Shaikh; Elizabeth Handorf; J Karen Wong; John P Hoffman; Sanjay Reddy; Harry S Cooper; Steven J Cohen; Efrat Dotan; Joshua E Meyer
Journal:  Ann Surg Oncol       Date:  2021-06-10       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.